Keywords: skyepharma, up, lodotra, recommendation, shares, uk, drug-delivery
Skyepharma up 14% on Lodotra recommendation
Article | 12 January 2009
Shares in UK drug-delivery firm SkyePharma shot up 14% after arthritis drug Lodotra (prednisone) was recommended for approval in 15 European countries ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
